Product
Grazoprevir
Aliases
MK-5172
3 clinical trials
3 indications
Indication
Hepatitis C Virus InfectionIndication
Hepatitis CIndication
ChronicClinical trial
A Phase IIb Clinical Study to Assess the Pharmacokinetics, Safety, and Efficacy of the Combination Regimen of Elbasvir (EBR)/Grazoprevir (GZR) in Participants Aged 3 to Less Than 18 Years With Chronic Hepatitis C InfectionStatus: Completed, Estimated PCD: 2019-10-28
Clinical trial
A Randomized, Partially Double-Blind, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly With Pegylated-Interferon and Ribavirin in Treatment-Naive Patients With Chronic Genotype 2 or 3 Hepatitis C Virus InfectionStatus: Terminated, Estimated PCD: 2012-05-01
Clinical trial
A Randomized, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Genotype 1 Hepatitis C Virus InfectionStatus: Completed, Estimated PCD: 2013-01-20